These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10924575)
1. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Abramson RG; Rosen MP; Perry LJ; Brophy DP; Raeburn SL; Stuart KE Radiology; 2000 Aug; 216(2):485-91. PubMed ID: 10924575 [TBL] [Abstract][Full Text] [Related]
2. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Sanz-Altamira PM; Spence LD; Huberman MS; Posner MR; Steele G; Perry LJ; Stuart KE Dis Colon Rectum; 1997 Jul; 40(7):770-5. PubMed ID: 9221850 [TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664 [TBL] [Abstract][Full Text] [Related]
4. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Gupta S; Bedikian AY; Ahrar J; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P Am J Clin Oncol; 2010 Oct; 33(5):474-80. PubMed ID: 19935383 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890 [TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901 [TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179 [TBL] [Abstract][Full Text] [Related]
9. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of intermittent hepatic arterial infusion chemotherapy for multiple liver metastasis of colorectal cancer]. Yoshioka S; Morimoto T; Shingai T; Azama T; Katsumoto Y; Nakaguchi K; Furukawa J; Okajima S; Sue F Gan To Kagaku Ryoho; 1999 Oct; 26(12):1721-4. PubMed ID: 10560380 [TBL] [Abstract][Full Text] [Related]
11. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207 [TBL] [Abstract][Full Text] [Related]
12. [Clinical outcome of intra-hepatic arterial infusion therapy for multiple liver metastases from colorectal cancer]. Okamoto N; Maruta M; Maeda K; Sato H; Takizawa K; Masumori K; Aoyama H; Kato R Gan To Kagaku Ryoho; 2003 Apr; 30(4):501-4. PubMed ID: 12722681 [TBL] [Abstract][Full Text] [Related]
13. [Weekly hepatic arterial infusion of high dose 5-fluorouracil for liver metastasis from colorectal cancer]. Takizawa K; Maruta M; Maeda K; Utsumi T; Masumori K; Matsumoto M; Koide Y; Aoyama H; Senda K; Ishihara O; Matsuoka H Gan To Kagaku Ryoho; 1999 Oct; 26(12):1718-20. PubMed ID: 10560379 [TBL] [Abstract][Full Text] [Related]
14. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408 [TBL] [Abstract][Full Text] [Related]
16. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer]. Zhao Y; Wang SM; Zhang J Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025 [TBL] [Abstract][Full Text] [Related]
17. Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study. Koperna T; Semmler D Hepatogastroenterology; 2003; 50(54):1903-9. PubMed ID: 14696430 [TBL] [Abstract][Full Text] [Related]
18. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. Yan TD; Padang R; Morris DL J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503 [TBL] [Abstract][Full Text] [Related]
19. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Ahrar J; Gupta S; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P; Bedikian AY Cancer Invest; 2011 Jan; 29(1):49-55. PubMed ID: 21166498 [TBL] [Abstract][Full Text] [Related]
20. Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Beard SM; Holmes M; Price C; Majeed AW Ann Surg; 2000 Dec; 232(6):763-76. PubMed ID: 11088071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]